Premenstrual syndrome. A general practice view.
Up to 95 per cent of women experience some physical or psychological symptoms in the premenstrual phase of the cycle. The authors describe the syndrome and provide a practical guide to management strategies for women experiencing severe symptoms in this part of their cycle.
McMurchie
M
M
Hindmarsh
E
E
D003276:Contraceptives, Oral / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008019:Life Style; D008528:Mefenamic Acid / Q000627:therapeutic use; D011293:Premenstrual Syndrome / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology; D011736:Pyridoxine / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D003276:Contraceptives, Oral; D013148:Spironolactone; D008528:Mefenamic Acid; D011736:Pyridoxine